Hepatitis C - peginterferon alfa and ribavirin: final appraisal determination - consultee and commentator comments on the ACD
Hepatitis C - peginterferon alfa and ribavirin: consultee and commentator comments on the ACD - Department of Health
Hepatitis C - peginterferon alfa and ribavirin: consultee and commentator comments on the ACD - MSD/Schering Plough
Hepatitis C - peginterferon alfa and ribavirin: consultee and commentator comments on the ACD - NHS Quality Improvement Scotland
Hepatitis C - peginterferon alfa and ribavirin: consultee and commentator comments on the ACD - Roche
Hepatitis C - peginterferon alfa and ribavirin: consultee and commentator comments on the ACD - Royal College of Nursing
Hepatitis C - peginterferon alfa and ribavirin: consultee and commentator comments on the ACD - Royal College of Pathologists
Hepatitis C - peginterferon alfa and ribavirin: consultee and commentator comments on the ACD - Southampton Health Technology Assessment Centre
This page was last updated: 12 August 2010